VIFOR PHARMA Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VIFOR PHARMA, and when can generic versions of VIFOR PHARMA drugs launch?
VIFOR PHARMA has one approved drug.
There are thirteen US patents protecting VIFOR PHARMA drugs.
There are one hundred and seventy-four patent family members on VIFOR PHARMA drugs in twenty-seven countries and thirty-two supplementary protection certificates in eighteen countries.
Drugs and US Patents for VIFOR PHARMA
Expired US Patents for VIFOR PHARMA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Vifor Pharma | VELTASSA | patiromer sorbitex calcium | POWDER;ORAL | 205739-003 | Oct 21, 2015 | 8,889,115 | ⤷ Try a Trial |
Vifor Pharma | VELTASSA | patiromer sorbitex calcium | POWDER;ORAL | 205739-004 | Oct 2, 2023 | 8,475,780 | ⤷ Try a Trial |
Vifor Pharma | VELTASSA | patiromer sorbitex calcium | POWDER;ORAL | 205739-001 | Oct 21, 2015 | 8,475,780 | ⤷ Try a Trial |
Vifor Pharma | VELTASSA | patiromer sorbitex calcium | POWDER;ORAL | 205739-003 | Oct 21, 2015 | 8,287,847 | ⤷ Try a Trial |
Vifor Pharma | VELTASSA | patiromer sorbitex calcium | POWDER;ORAL | 205739-004 | Oct 2, 2023 | 8,778,324 | ⤷ Try a Trial |
Vifor Pharma | VELTASSA | patiromer sorbitex calcium | POWDER;ORAL | 205739-004 | Oct 2, 2023 | 10,485,821 | ⤷ Try a Trial |
Vifor Pharma | VELTASSA | patiromer sorbitex calcium | POWDER;ORAL | 205739-003 | Oct 21, 2015 | 10,485,821 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VIFOR PHARMA Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Poland | 1732523 | ⤷ Try a Trial |
Japan | 5431439 | ⤷ Try a Trial |
Portugal | 2184059 | ⤷ Try a Trial |
Portugal | 3219312 | ⤷ Try a Trial |
South Korea | 20120060920 | ⤷ Try a Trial |
San Marino | T201500207 | ⤷ Try a Trial |
European Patent Office | 2916851 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for VIFOR PHARMA Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2957286 | C 2019 004 | Romania | ⤷ Try a Trial | PRODUCT NAME: PATIROMER SORBITEX SARE DE CALCIU; NATIONAL AUTHORISATION NUMBER: EU/1/17/1179/001-009; DATE OF NATIONAL AUTHORISATION: 20170719; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/17/1179/001-009; DATE OF FIRST AUTHORISATION IN EEA: 20170719 |
2957286 | C201930008 | Spain | ⤷ Try a Trial | PRODUCT NAME: PATIROMERO; NATIONAL AUTHORISATION NUMBER: EU/1/17/1179; DATE OF AUTHORISATION: 20170719; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/17/1179; DATE OF FIRST AUTHORISATION IN EEA: 20170719 |
2365988 | 2018C/006 | Belgium | ⤷ Try a Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM OF EERDER WELK ZOUT OF AFGELEIDE ERVAN; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721 |
2957286 | PA2018016 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: PATIROMERO, SORBITOLIO IR KALCIO KOMPLEKSAS; REGISTRATION NO/DATE: EU/1/17/1179 20170719 |
2365988 | 122018000012 | Germany | ⤷ Try a Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM UND SALZE DAVON IN ALLEN VOM GRUNDPATENT GESCHUETZTEN FORMEN; REGISTRATION NO/DATE: EU/1/17/1179 20170719 |
2957286 | LUC00094 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721 |
2957286 | 18C1053 | France | ⤷ Try a Trial | PRODUCT NAME: PATIROMER; NAT. REGISTRATION NO/DATE: EU/1/17/1179 20170721; FIRST REGISTRATION: - EU/1/17/1179 20170721 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.